Medicus Sciences Acquisition Corp. (MSAC)
Medicus Sciences Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $10.17, up 0.05% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of 56.50, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Medicus Sciences Acquisition Corp., founded in 2020 and headquartered in New York, New York, currently has no substantial independent business activities. Its main goal is to execute a business combination—such as a merger, stock exchange, asset purchase, or reorganization—with one or more enterprises. The company's strategic focus is on the healthcare industry, particularly the medical technology sector, seeking opportunities both domestically in the United States and around the world.
Medicus Sciences Acquisition Corp. is most often compared with the following Financial Services names: